Evidence map›Paper›PMID 42405348›Full record

ArticleJAC-antimicrobial resistance2026

Microbiological findings, antibiotic resistance rates and prescription practices for older women with recurrent urinary tract infections: a descriptive study alongside a multinational randomized controlled trial (ImpresU).

Silje Rebekka Heltveit-Olsen, Nils Grude, Egill Snaebjörnsson Arnljots, Pär-Daniel Sundvall, Ronny Gunnarsson, Anna Kowalczyk, Maciej Godycki-Cwirko, Tamara N Platteel, Wim G Groen, Sara Sofia Lithén and 7 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in JAC-antimicrobial resistance, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Silje Rebekka Heltveit-OlsenThe Antibiotic Centre for Primary Care, Department of General Practice, Institute of Health and Society, University of Oslo, P.O. Box 1130 Blindern, Oslo 0318, Norway.ORCID https://orcid.org/0000-0002-8645-5836
Nils GrudeThe Antibiotic Centre for Primary Care, Department of General Practice, Institute of Health and Society, University of Oslo, P.O. Box 1130 Blindern, Oslo 0318, Norway.
Egill Snaebjörnsson ArnljotsGeneral Practice/Family Medicine, School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Box 453, Gothenburg SE-405 30, Sweden.
Pär-Daniel SundvallGeneral Practice/Family Medicine, School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Box 453, Gothenburg SE-405 30, Sweden.ORCID https://orcid.org/0000-0001-9889-509X
Ronny GunnarssonGeneral Practice/Family Medicine, School of Public Health and Community Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Box 453, Gothenburg SE-405 30, Sweden.ORCID https://orcid.org/0000-0001-9183-3072
Anna KowalczykCentre for Family and Community Medicine, the Faculty of Health Sciences, The Medical University of Lodz, Lodz 90-419, Poland.ORCID https://orcid.org/0000-0002-7524-2085
Maciej Godycki-CwirkoCentre for Family and Community Medicine, the Faculty of Health Sciences, The Medical University of Lodz, Lodz 90-419, Poland.ORCID https://orcid.org/0000-0002-9204-5518
Tamara N PlatteelJulius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Universiteitsweg 100, Utrecht 3584 CG, The Netherlands.ORCID https://orcid.org/0000-0001-5122-0079
Wim G GroenDepartment of Medicine for Older People, Amsterdam UMC, Vrije Universiteit Amsterdam, De Boelelaan 1117, Amsterdam 1081 HV, The Netherlands.
Sara Sofia LithénThe Antibiotic Centre for Primary Care, Department of General Practice, Institute of Health and Society, University of Oslo, P.O. Box 1130 Blindern, Oslo 0318, Norway.ORCID https://orcid.org/0009-0001-8725-5959
Sofia SundvallFoUUI-Centrum Södra Älvsborg, Research, Education, Development & Innovation, Primary Health Care, Region Västra Götaland, Sweden, Sven Eriksonsplatsen 4, Borås SE-503 38, Sweden.
Nahid KaramiCentrum for Antibiotic Resistance Research (CARe), University of Gothenburg, Gothenburg, Sweden.
Theo J M VerheijJulius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Universiteitsweg 100, Utrecht 3584 CG, The Netherlands.
Cees M P M HertoghDepartment of Medicine for Older People, Amsterdam UMC, Vrije Universiteit Amsterdam, De Boelelaan 1117, Amsterdam 1081 HV, The Netherlands.
Morten LindbækThe Antibiotic Centre for Primary Care, Department of General Practice, Institute of Health and Society, University of Oslo, P.O. Box 1130 Blindern, Oslo 0318, Norway.
Christina ÅhrénCentrum for Antibiotic Resistance Research (CARe), University of Gothenburg, Gothenburg, Sweden.
Sigurd HøyeThe Antibiotic Centre for Primary Care, Department of General Practice, Institute of Health and Society, University of Oslo, P.O. Box 1130 Blindern, Oslo 0318, Norway.ORCID https://orcid.org/0000-0003-1806-3811

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: To describe microbiological findings during asymptomatic and symptomatic phases in older women with recurrent urinary tract infections (rUTIs), to evaluate whether antimicrobial resistance patterns of Methods: This was a descriptive study alongside a multinational randomized controlled trial (ImpresU). Women aged ≥70 years with rUTIs were recruited from general practice in Norway, Sweden, Poland and the Netherlands between December 2019 and June 2022. Participants were randomized to methenamine hippurate 1 g or placebo twice daily for 6 months, followed by a 6 month follow-up period. Urinary samples were collected at baseline (asymptomatic) and during acute UTIs. Results: We included 281 women. A dominating uropathogen ≥10 Conclusions: Physicians should be aware that 29% of older women with rUTIs in the community may have significant bacterial findings in their urine during asymptomatic phases.

Identifiers

PMID42405348
PMCPMC13332803

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.